• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种机器学习模型预测肝内胆管癌早期复发。

Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.

机构信息

Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.

Department of Surgery, University of Verona, Verona, Italy.

出版信息

Ann Surg Oncol. 2023 Sep;30(9):5406-5415. doi: 10.1245/s10434-023-13636-8. Epub 2023 May 20.

DOI:10.1245/s10434-023-13636-8
PMID:37210452
Abstract

BACKGROUND

The high incidence of early recurrence after hepatectomy for intrahepatic cholangiocarcinoma (ICC) has a detrimental effect on overall survival (OS). Machine-learning models may improve the accuracy of outcome prediction for malignancies.

METHODS

Patients who underwent curative-intent hepatectomy for ICC were identified using an international database. Three machine-learning models were trained to predict early recurrence (< 12 months after hepatectomy) using 14 clinicopathologic characteristics. The area under the receiver operating curve (AUC) was used to assess their discrimination ability.

RESULTS

In this study, 536 patients were randomly assigned to training (n = 376, 70.1%) and testing (n = 160, 29.9%) cohorts. Overall, 270 (50.4%) patients experienced early recurrence (training: n = 150 [50.3%] vs testing: n = 81 [50.6%]), with a median tumor burden score (TBS) of 5.6 (training: 5.8 [interquartile range {IQR}, 4.1-8.1] vs testing: 5.5 [IQR, 3.7-7.9]) and metastatic/undetermined nodes (N1/NX) in the majority of the patients (training: n = 282 [75.0%] vs testing n = 118 [73.8%]). Among the three different machine-learning algorithms, random forest (RF) demonstrated the highest discrimination in the training/testing cohorts (RF [AUC, 0.904/0.779] vs support vector machine [AUC, 0.671/0.746] vs logistic regression [AUC, 0.668/0.745]). The five most influential variables in the final model were TBS, perineural invasion, microvascular invasion, CA 19-9 lower than 200 U/mL, and N1/NX disease. The RF model successfully stratified OS relative to the risk of early recurrence.

CONCLUSIONS

Machine-learning prediction of early recurrence after ICC resection may inform tailored counseling, treatment, and recommendations. An easy-to-use calculator based on the RF model was developed and made available online.

摘要

背景

肝内胆管癌(ICC)患者行肝切除术后早期复发的发生率较高,这对总体生存(OS)有不利影响。机器学习模型可能会提高恶性肿瘤预后预测的准确性。

方法

使用国际数据库确定接受根治性肝切除术治疗 ICC 的患者。使用 14 种临床病理特征,训练三种机器学习模型来预测早期复发(肝切除术后<12 个月)。使用接受者操作特征曲线下的面积(AUC)评估其鉴别能力。

结果

本研究中,536 名患者被随机分配到训练(n=376,70.1%)和测试(n=160,29.9%)队列。总体而言,270 名(50.4%)患者发生早期复发(训练:n=150[50.3%] vs 测试:n=81[50.6%]),肿瘤负担评分(TBS)中位数为 5.6(训练:5.8 [四分位距 {IQR},4.1-8.1] vs 测试:5.5 [IQR,3.7-7.9]),且大多数患者存在转移性/不确定的淋巴结(N1/NX)(训练:n=282[75.0%] vs 测试:n=118[73.8%])。在三种不同的机器学习算法中,随机森林(RF)在训练/测试队列中的鉴别能力最高(RF[AUC,0.904/0.779] vs 支持向量机[AUC,0.671/0.746] vs 逻辑回归[AUC,0.668/0.745])。最终模型中五个最具影响力的变量是 TBS、神经周围侵犯、微血管侵犯、CA19-9 低于 200 U/mL 和 N1/NX 疾病。RF 模型成功地根据早期复发的风险对 OS 进行了分层。

结论

ICC 切除术后早期复发的机器学习预测可能有助于提供有针对性的咨询、治疗和建议。基于 RF 模型开发了一个易于使用的计算器,并在网上提供。

相似文献

1
Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.开发和验证一种机器学习模型预测肝内胆管癌早期复发。
Ann Surg Oncol. 2023 Sep;30(9):5406-5415. doi: 10.1245/s10434-023-13636-8. Epub 2023 May 20.
2
The Application of Artificial Intelligence to Investigate Long-Term Outcomes and Assess Optimal Margin Width in Hepatectomy for Intrahepatic Cholangiocarcinoma.人工智能在肝内胆管癌肝切除术中调查长期结果和评估最佳切缘宽度的应用。
Ann Surg Oncol. 2023 Jul;30(7):4292-4301. doi: 10.1245/s10434-023-13349-y. Epub 2023 Mar 23.
3
Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.基于 CECT 的机器学习放射组学预测肝内胆管细胞癌根治性切除术后早期复发:多中心研究。
Comput Biol Med. 2023 Dec;167:107612. doi: 10.1016/j.compbiomed.2023.107612. Epub 2023 Oct 31.
4
Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.肿瘤负担评分和癌胚抗原可预测肝切除术后肝内胆管细胞癌患者的结局:一项多机构分析。
BMC Cancer. 2024 Mar 20;24(1):358. doi: 10.1186/s12885-024-12091-2.
5
Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.危害函数在研究根治性肝切除术后肝内胆管细胞癌复发中的应用:一种描述复发的新方法。
Ann Surg Oncol. 2023 Mar;30(3):1340-1349. doi: 10.1245/s10434-022-12463-7. Epub 2022 Aug 27.
6
Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma.机器学习放射组学可预测肝内胆管细胞癌切除术后早期肝复发。
HPB (Oxford). 2022 Aug;24(8):1341-1350. doi: 10.1016/j.hpb.2022.02.004. Epub 2022 Feb 17.
7
Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.肝内胆管细胞癌切除术后早期复发:考虑替代治疗方法。
JAMA Surg. 2020 Sep 1;155(9):823-831. doi: 10.1001/jamasurg.2020.1973.
8
Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study.机器学习放射组学预测根治性切除术后肝内胆管癌的早期复发:多中心队列研究。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2501-2513. doi: 10.1007/s00259-023-06184-6. Epub 2023 Mar 16.
9
Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma.基于可解释机器学习的临床预测模型,用于预测肝内胆管细胞癌患者的淋巴结转移。
BMC Gastroenterol. 2024 Apr 19;24(1):137. doi: 10.1186/s12876-024-03223-w.
10
Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.肝内胆管细胞癌肿瘤负荷:一种分类和回归树模型,用于定义手术后的预后分组。
Surgery. 2019 Dec;166(6):983-990. doi: 10.1016/j.surg.2019.06.005. Epub 2019 Jul 17.

引用本文的文献

1
Monitoring miR-29a for targeted therapy of cholangiocarcinoma based on a photoelectric sensor.基于光电传感器监测miR-29a用于胆管癌的靶向治疗
Mikrochim Acta. 2025 Aug 14;192(9):592. doi: 10.1007/s00604-025-07424-2.
2
Preoperative Prediction of Microvascular Invasion in Intrahepatic Cholangiocarcinoma and Its Prognostic Implications: A Multicenter Study.肝内胆管癌微血管侵犯的术前预测及其预后意义:一项多中心研究
Liver Cancer. 2025 Jun 24. doi: 10.1159/000547071.
3
What is the role of artificial intelligence in general surgery?

本文引用的文献

1
Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.危害函数在研究根治性肝切除术后肝内胆管细胞癌复发中的应用:一种描述复发的新方法。
Ann Surg Oncol. 2023 Mar;30(3):1340-1349. doi: 10.1245/s10434-022-12463-7. Epub 2022 Aug 27.
2
The focus clinical research in intrahepatic cholangiocarcinoma.肝内胆管细胞癌的重点临床研究。
Eur J Med Res. 2022 Jul 11;27(1):116. doi: 10.1186/s40001-022-00741-9.
3
Factors of Early Recurrence After Resection for Intrahepatic Cholangiocarcinoma.
人工智能在普通外科中的作用是什么?
Ewha Med J. 2024 Apr;47(2):e22. doi: 10.12771/emj.2024.e22. Epub 2024 Apr 30.
4
Who benefits from adjuvant chemotherapy? Identification of early recurrence in intrahepatic cholangiocarcinoma patients after curative-intent resection using machine learning algorithms.谁能从辅助化疗中获益?使用机器学习算法识别肝内胆管癌患者根治性切除术后的早期复发情况。
Front Oncol. 2025 Jun 6;15:1594200. doi: 10.3389/fonc.2025.1594200. eCollection 2025.
5
Diagnosis of Cholangiocarcinoma: The New Biological and Technological Horizons.胆管癌的诊断:新的生物学与技术前沿
Diagnostics (Basel). 2025 Apr 16;15(8):1011. doi: 10.3390/diagnostics15081011.
6
Artificial intelligence in predicting recurrence after first-line treatment of liver cancer: a systematic review and meta-analysis.人工智能在预测肝癌一线治疗后复发中的应用:系统评价和荟萃分析。
BMC Med Imaging. 2024 Oct 7;24(1):263. doi: 10.1186/s12880-024-01440-z.
7
Can we talk about "futile surgery" for the upfront treatment of the perihilar cholangiocarcinoma?我们可以谈谈关于肝门部胆管癌初始治疗中的“无效手术”吗?
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):672-674. doi: 10.21037/hbsn-24-290. Epub 2024 Jul 23.
8
Machine learning to predict the early recurrence of intrahepatic cholangiocarcinoma: A systematic review and meta‑analysis.机器学习预测肝内胆管癌早期复发:一项系统综述和荟萃分析。
Oncol Lett. 2024 Jun 20;28(2):385. doi: 10.3892/ol.2024.14518. eCollection 2024 Aug.
9
The Prognostic Value of Preoperative Serum Markers and Risk Classification in Patients with Hepatocellular Carcinoma.术前血清标志物对肝细胞癌患者的预后价值及风险分类
Ann Surg Oncol. 2024 Jul;31(7):4468-4469. doi: 10.1245/s10434-024-15411-9. Epub 2024 May 7.
10
Application of AI on cholangiocarcinoma.人工智能在胆管癌中的应用。
Front Oncol. 2024 Jan 29;14:1324222. doi: 10.3389/fonc.2024.1324222. eCollection 2024.
肝内胆管癌切除术后早期复发的因素
World J Surg. 2022 Oct;46(10):2459-2467. doi: 10.1007/s00268-022-06655-1. Epub 2022 Jul 11.
4
A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis.一种用于预测肝内胆管癌患者早期复发以指导辅助化疗的列线图模型:多机构分析
Front Oncol. 2022 Jun 23;12:896764. doi: 10.3389/fonc.2022.896764. eCollection 2022.
5
Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study.肝内胆管癌神经周围侵犯的预后影响:多中心研究
Br J Surg. 2022 Jun 14;109(7):610-616. doi: 10.1093/bjs/znac098.
6
Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study.肿瘤负荷评分对肝切除术后肝内胆管癌患者的预后进行分层:一项回顾性多机构研究
Front Oncol. 2022 Mar 7;12:829407. doi: 10.3389/fonc.2022.829407. eCollection 2022.
7
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.随机 III 期 BILCAP 研究的长期结果和探索性分析。
J Clin Oncol. 2022 Jun 20;40(18):2048-2057. doi: 10.1200/JCO.21.02568. Epub 2022 Mar 22.
8
Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach.肝内胆管癌的治疗——多学科方法
Cancers (Basel). 2022 Jan 12;14(2):362. doi: 10.3390/cancers14020362.
9
Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs.胆管癌的药物治疗进展:从传统治疗到靶向药物。
Expert Opin Pharmacother. 2022 Mar;23(4):473-481. doi: 10.1080/14656566.2021.2020250. Epub 2021 Dec 29.
10
Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy.人工智能在泌尿科中的应用:监督机器学习算法在预测前列腺切除术后生化复发方面优于列线图。
Prostate. 2022 Feb;82(3):298-305. doi: 10.1002/pros.24272. Epub 2021 Dec 2.